CRISPRX

Serial Number 97558002
733

Registration Progress

Application Filed
Aug 22, 2022
Under Examination
Jul 4, 2023
Approved for Publication
May 9, 2023
Published for Opposition
May 9, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jan 04, 2026 11 days

Trademark Image

CRISPRX

Basic Information

Serial Number
97558002
Filing Date
August 22, 2022
Published for Opposition
May 9, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Jun 12, 2025
Application
Pending
Classes
042

Rights Holder

CRISPR Therapeutics AG

99
Address
Baarerstrasse 14
ZUG V8 6300
CH

Ownership History

CRISPR Therapeutics AG

Original Applicant
99
ZUG V8 SWITZERLAND CH

CRISPR Therapeutics AG

Owner at Publication
99
ZUG V8 CH

Legal Representation

Attorney
Tiffany D. Gehrke

USPTO Deadlines

Next Deadline
11 days remaining
NOA E-Mailed - SOU Required
Due Date
January 04, 2026
Extension Available
Until July 04, 2026

Application History

30 events
Date Code Type Description Documents
Dec 22, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 12, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 12, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 12, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 11, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 10, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 10, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 9, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 9, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 29, 2024 PCDE O PETITION TO DIRECTOR DENIED Loading...
Feb 26, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Dec 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 18, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 18, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 8, 2023 TPDR I TEAS PETITION TO DIRECTOR RECEIVED Loading...
Jul 4, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 9, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 9, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 19, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 31, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 31, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 13, 2023 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Feb 13, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Sep 11, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Classification

International Classes
042